MR Elastography of The Prostate with A Mode-Conversion Endourethral Driver: Feasibility at 3.0 T
Jin Wang1, Kevin J. Glaser2, Bingjun He1, Tianhui Zhang1, Jun Pang3, Ziying Yin2, Zhuang Kang1, Qungang Shan1, Meng Yin2, Forghanian-Arani Arvin2, and Richard L. Ehman2

1Department of Radiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, People's Republic of, 2Department of Radiology, Mayo Clinic, Rochester, MN, United States, 3Department of Urology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, People's Republic of

Synopsis

Prostate cancer(PCa) is one of the leading causes of cancer-related deaths in men. Detection of clinically significant PCa is a major challenge. We evaluated the feasibility of a novel approach for quantitatively imaging the stiffness of prostate gland, using a conventional urinary catheter as a source of shear waves for MR elastography. Results in 19 examinations showed that the approach, which uses conventional commercially-available MRE drivers can generate shear wave fields in the prostate that are suitable processing. Measurements of regional prostate stiffness in patients with benign prostatic hypertrophy and PCa reveal trends that provide motivation for further evaluation of prostatic MRE.

Purpose

Prostate cancer(PCa) has the high incidence and is the second most common cause of cancer-related deaths in the male population1. Detection of clinically significant PCa is a major challenge. MR imaging is a useful tool for PCa detection and staging, with a promising role in risk stratification2. MR Elastography (MRE) is a method to probe the mechanical properties of tissue, and has been shown to be useful in many diagnostic applications3, and has potential to provide complementary information for improving the diagnosis of PCa. The aim of our study was to evaluate the technical feasibility and potential diagnostic value of MRE of the prostate gland, using a novel approach to generate shear waves in the prostate via mode conversion, using a conventional urinary catheter.

Methods

This pilot study enrolled 19 patients (mean age: 71.47±9.43 years; range: 43–82 years;mean body mass index: 21.51±3.41 kg/m2; range: 14.98–27.55 kg/m2), including 16 patients with benign prostate hyperplasia (BPH) and 3 with prostatic cancer(PCa) proven by biopsy results and clinical follow up. Preoperative prostate-specific antigen(PSA, 0-5ng/ml) and free-PSA(F-PSA, 0-1 ng/ml) were retrospectively evaluated. MRE of the prostate gland was performed within one week prior to pathological examination. All patients had conventional rubber urethral catheters in place at the time of examination. An active MRE acoustic driver system with a passive drum driver (Resoundant Inc., Rochester, MN), normally used for liver MRE, was positioned over the lower abdominal wall partially overlapping the superior border of the symphysis pubis. MRE was performed on a 3.0T scanner (GE, Discovery MR750) with a free-breathing, multislice, single-shot, flow-compensated, spin-echo EPI, 2D-MRE sequence using 60-Hz vibrations (acquisition matrix = 80x80; parallel imaging factor of 2;TR/TE =1667/56.3ms; 4 time points; scan time = 40 sec; 24-cm FOV; 20 3-mm axial slices; through-plane motion encoding with bipolar, 6.45-ms, 50-mT/m motion-encoding gradients on each side of the refocusing pulse).The MRE magnitude and phase images were processed using the multi-model direct inversion algorithm (MMDI)to calculate the stiffness. Stiffness maps were automatically generated by the software on the MR scanner and displayed. The reliability of stiffness measurement was assessed by measuring the SNR of the magnitude images and the encoded amplitude of the acoustic waves. Regions of interest(ROIs) were drawn in the central zone(CZ), the peripheral zone(PZ) and in the PCa area, and were adjusted to exclude areas with the prostatic catheter, prostate edges, significant wave interference. Mean prostate stiffness (in kilopascals (kPa)) within the ROIs was recorded. The t-test was used to test for differences in the stiffness of the CZ and PZ in BPH, and to compare the stiffness between PCa and BPH. Statistical significance was defined as P<0.05.

Results

The PSA and F-PSA were 9.17 ng/ml (median, range: 0.77-179.02ng/ml) and 2.40 ng/ml(median, range: 0.23-159.52ng/ml ) in BPH patients, and 155.08 ng/ml( median, range: 36.48-306.88ng/ml) and 8.81ng/ml(median, range: 5.99-14.47ng/ml) in PCa patients, respectively. As illustrated in Figures 1b,1e and 1h, Mechanical waves were successfully propagated into the prostate gland in all patients, except for the regions near transurethral catheter. The mean stiffness values were 4.28±0.79 kPa (range: 3.05-5.29 kPa) in the CZ, and 3.11±0.69 kPa (range: 2.14-4.51 kPa) in the PZ in BPH group (Figures 1c and 1f). The difference between CZ and PZ was statistically significant (P<0.001). The mean stiffness value of regions of PCa was 6.10±1.72kPa (range: 4.20-7.52 kPa) (Figure 1i), which was higher than the mean PZ stiffness of patients with BPH (P<0.001), but was not significantly different from the mean CZ stiffness in regions with BPH (P=0.203).

Discussion

A number of approaches for illuminating shear waves into the prostate have been proposed, including abdominal, perineal, and endorectal drivers3-7. We previously found that a vibration source attached to a conventional urinary catheter couldgenerate ideal cylindrical wave fields in the prostate, radiating from the urethral margin. This study demonstrated that similar results can be achieved using a conventional abdominal driver, when a urinary catheter is in place. The most likely explanation for the mechanism is that longitudinal waves from the abdominal driver are mode-converted to shear waves at the catheter-uretheral interface. Our preliminary measurements indicated that the CZ is significantly stiffer than the PZ in patients with BPH and that the stiffness of PCa was higher than that of the PZ in BPH. Further development of this technique is warranted.

Conclusion

MRE has a potential role for providing additional information for improved diagnosis and localization of prostate diseases.

Acknowledgements

No acknowledgement found.

References

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015, 65(1):5-29.

2. Costa DN, Pedrosa I, Roehrborn C, et al. Multiparametric magnetic resonance imaging of the prostate: technical aspects and role in clinical management.TopMagnReson Imaging. 2014, 23(4): 243-57

3. Sahebjavaher RS, Nir G, Honarvar M, et al. MR elastography of prostate cancer: quantitative comparison with histopathology and repeatability of methods. NMR Biomed. 2015, 28(1):124-39.

4. Chopra R, Arani A, Huang Y, et al. In vivo MR elastography of the prostate gland using a transurethral actuator. Magn Reson Med. 2009, 62(3):665-71.

5. Arani A, Da Rosa M, Ramsay E, et al. Incorporating endorectal MR elastography into multi-parametric MRI for prostate cancer imaging: Initial feasibility in volunteers. J Magn Reson Imaging. 2013, 38(5):1251-60.

6. Sahebjavaher RS, Nir G, Gagnon LO, et al. MR elastography and diffusion-weighted imaging of ex vivo prostate cancer: quantitative comparison to histopathology. NMR Biomed. 2015, 28(1): 89-100.

7. Li S, Chen M, Wang W, et al. A feasibility study of MR elastography in the diagnosis of prostate cancer at 3.0T. Acta Radiol. 2011, 52(3):354-8.

Figures

Figure 1: T2WI (a, d, and g) and MRE images of 3 patients.Top:a 65-year-old male with BPH. Middle: a 65-year-old male with BPH. Bottom: an 82-year-old male with PCa. (b, e, and h) Wave images at 60 Hz. (c,f, and i) Stiffness maps.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0712